Cargando…

Effects of high-dose docosahexaenoic acid supplementation as an add-on therapy for canine idiopathic epilepsy: A pilot study

BACKGROUND: The anti-epileptic effects of docosahexaenoic acid (DHA) in dogs and humans remain controversial. The dosage and efficacy of DHA were various in the previous reports. AIM: The effects of high-dose DHA supplementation as add-on therapy for idiopathic epilepsy in dogs were evaluated. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yonezawa, Tomohiro, Marasigan, Cris Niño Bon B., Matsumiya, Yuki, Maeda, Shingo, Motegi, Tomoki, Momoi, Yasuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculty of Veterinary Medicine 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443822/ https://www.ncbi.nlm.nih.gov/pubmed/37614731 http://dx.doi.org/10.5455/OVJ.2023.v13.i7.14

Ejemplares similares

Evaluation of antiseizure medications including zonisamide in feline idiopathic epilepsy at a referral hospital in Japan
por: Yoshida, Shino, et al.
Publicado: (2023)

Detection of Canine Urothelial Carcinoma Cells in Urine Using 5-Aminolevulinic Acid
por: Kaji, Kenjiro, et al.
Publicado: (2022)

Sorafenib inhibits tumor cell growth and angiogenesis in canine transitional cell carcinoma
por: YOKOTA, Shohei, et al.
Publicado: (2022)

Clinical assessment of testosterone analogues for urethral sphincter mechanism incompetence in ten spayed female dogs
por: NISHI, Reo, et al.
Publicado: (2021)

Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer
por: Maeda, Shingo, et al.
Publicado: (2022)

Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs
por: Maeda, Shingo, et al.
Publicado: (2022)

Synovial fluid total protein concentration as a possible marker for canine idiopathic polyarthritis
por: MURAKAMI, Kohei, et al.
Publicado: (2015)

Apoptosis inhibitor of macrophage (AIM) reduces cell number in canine histiocytic sarcoma cell lines
por: UCHIDA, Mona, et al.
Publicado: (2016)

Cognitive dysfunction in naturally occurring canine idiopathic epilepsy
por: Packer, Rowena M. A., et al.
Publicado: (2018)

Cyclooxygenase-2 Inhibition as an Add-On Strategy in Drug Resistant Epilepsy—A Canine Translational Study
por: Fischer, Andrea, et al.
Publicado: (2022)

Rapid visualization of mammary gland tumor lesions of dogs using the enzyme-activated fluorogenic probe; γ-glutamyl hydroxymethyl rhodamine green
por: HIROSE, Yui, et al.
Publicado: (2022)

Headaches add to the burden of epilepsy
por: Syvertsen, Marte, et al.
Publicado: (2007)

ErbB2 copy number gain is associated with adverse outcome in canine mammary carcinoma
por: SAKAI, Kosei, et al.
Publicado: (2021)

Gut Microbiota in Canine Idiopathic Epilepsy: Effects of Disease and Treatment
por: García-Belenguer, Sylvia, et al.
Publicado: (2021)

Analysis of DNA methylation of potential age-related methylation sites in canine peripheral blood leukocytes
por: ITO, Genta, et al.
Publicado: (2017)

ADAM23 is a common risk gene for canine idiopathic epilepsy
por: Koskinen, Lotta L. E., et al.
Publicado: (2017)

Sphingosine-1-phosphate (S1P) signaling regulates the production of intestinal IgA and its potential role in the pathogenesis of canine inflammatory bowel disease
por: NAKAZAWA, Maho, et al.
Publicado: (2019)

Contrasting treatment responses by Burkholderia cepacia complex-related deep pyoderma: A series of two cases
por: Shinomiya, Yuki, et al.
Publicado: (2022)

Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq
por: Maeda, Shingo, et al.
Publicado: (2018)

Felbamate as an oral add-on therapy in six dogs with presumptive idiopathic epilepsy and generalized seizures resistant to drug therapy
por: Dewey, Curtis Wells, et al.
Publicado: (2022)

Identification of a common risk haplotype for canine idiopathic epilepsy in the ADAM23 gene
por: Koskinen, Lotta L. E., et al.
Publicado: (2015)

Imepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs
por: Rundfeldt, C, et al.
Publicado: (2014)

Cross Sectional Survey of Canine Idiopathic Epilepsy Management in Primary Care in the United Kingdom
por: Griffin, Sebastian, et al.
Publicado: (2022)

Effect of clobazam as add-on antiepileptic drug in patients with epilepsy
por: Joshi, Rupa, et al.
Publicado: (2014)

Jacksonian Epilepsy in Idiopathic Epilepsy
Publicado: (1910)

The effect of docosahexaenoic acid on predicting the survival of patients with idiopathic pulmonary arterial hypertension
por: Huai, Xu, et al.
Publicado: (2021)

Ganglion Cysts Arising from a Canine Stifle Joint
por: MURATA, Daiki, et al.
Publicado: (2013)

Synovial fluid matrix metalloproteinase-2 and -9 activities in dogs suffering from joint disorders
por: MURAKAMI, Kohei, et al.
Publicado: (2016)

Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation
por: Teopompi, Elisabetta, et al.
Publicado: (2019)

Identification of dysregulated microRNAs in canine malignant melanoma
por: Ushio, Norio, et al.
Publicado: (2019)

Alteration of somatostatin receptor 2 expression in canine mammary gland tumor
por: SAKAI, Kosei, et al.
Publicado: (2015)

Economic Evaluation of Add-on Levetiracetam for the Treatment of Refractory Partial Epilepsy in Korea
por: Suh, Guk-Hee, et al.
Publicado: (2009)

Evaluation of the efficacy and tolerability of levetiracetam as add-on therapy in intractable epilepsy of children
por: Razieh, Razieh, et al.
Publicado: (2022)

Pregabalin Add-On vs. Dose Increase in Levetiracetam Add-On Treatment: A Real-Life Trial in Dogs With Drug-Resistant Epilepsy
por: Kriechbaumer, Sandra R. P., et al.
Publicado: (2022)

The Nature of "Idiopathic" Epilepsy
Publicado: (1908)

The Renoprotective Effects of Docosahexaenoic Acid as an Add-on Therapy in Patients Receiving Eicosapentaenoic Acid as Treatment for IgA Nephropathy: A Pilot Uncontrolled Trial
por: Moriyama, Takahito, et al.
Publicado: (2017)

Understanding epilepsy in a canine model
Publicado: (2011)

Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
por: Fernandes, Caio J.C.S., et al.
Publicado: (2021)

Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy
por: CHONAN, Masashi, et al.
Publicado: (2020)

Hydroperoxidation of Docosahexaenoic Acid by Human ALOX12 and pigALOX15-mini-LOX
por: Canyelles-Niño, Miquel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1rb7178tdse52s7md60p9s039q